ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 7.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $46,718,000 | +220.5% | 2,477,066 | +100.0% | 0.34% | +56.8% |
Q2 2019 | $14,578,000 | -13.8% | 1,238,533 | 0.0% | 0.22% | -33.7% |
Q1 2019 | $16,906,000 | +33.2% | 1,238,533 | 0.0% | 0.33% | +62.0% |
Q4 2018 | $12,695,000 | -38.4% | 1,238,533 | 0.0% | 0.20% | -21.8% |
Q3 2018 | $20,622,000 | +5.4% | 1,238,533 | 0.0% | 0.26% | +1.9% |
Q2 2018 | $19,569,000 | +24.4% | 1,238,533 | 0.0% | 0.26% | +8.4% |
Q1 2018 | $15,729,000 | +10.9% | 1,238,533 | 0.0% | 0.24% | +8.7% |
Q4 2017 | $14,181,000 | -6.5% | 1,238,533 | 0.0% | 0.22% | -11.4% |
Q3 2017 | $15,172,000 | +7.0% | 1,238,533 | 0.0% | 0.25% | +27.5% |
Q2 2017 | $14,181,000 | -45.0% | 1,238,533 | 0.0% | 0.19% | -37.9% |
Q1 2017 | $25,761,000 | 0.0% | 1,238,533 | 0.0% | 0.31% | +11.9% |
Q4 2016 | $25,761,000 | -36.5% | 1,238,533 | 0.0% | 0.28% | -32.2% |
Q3 2016 | $40,587,000 | +31.2% | 1,238,533 | 0.0% | 0.41% | +20.9% |
Q2 2016 | $30,926,000 | +2.0% | 1,238,533 | 0.0% | 0.34% | +12.6% |
Q1 2016 | $30,332,000 | -25.9% | 1,238,533 | 0.0% | 0.30% | +1.7% |
Q4 2015 | $40,909,000 | +0.8% | 1,238,533 | 0.0% | 0.30% | +51.0% |
Q3 2015 | $40,574,000 | -38.2% | 1,238,533 | 0.0% | 0.20% | -35.3% |
Q2 2015 | $65,605,000 | -8.7% | 1,238,533 | -50.2% | 0.30% | -16.5% |
Q1 2015 | $71,819,000 | – | 2,488,533 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |